Medtecs soon to begin distributing RespireAid (NRICM101) in the Philippines and Cambodia

NRICM101-Medtecs Respire Aid

(TAIPEI, September 22, 2021) Medtecs International Corporation Limited (“Medtecs”) is pleased to announce that the company will manage the distribution of RespireAid (NRICM101) in the Philippines and Cambodia. The traditional Chinese herbal compound is developed in Taiwan and has already been proven effective for the treatment of Covid-19.

RespireAid (NRICM101)

The Cambodian authority has certified RespireAid (NRICM101) for sale earlier this month. The official approval will facilitate the distribution of the supplement and boost consumer confidence in the safety and efficacy of RespireAid (NRICM101).

The supplement was developed by the National Research Institute of Chinese Medicine (NRICM) in Taiwan. Evidence-based clinical trials were conducted on the compound and the results have shown RespireAid (NRICM101) to be effective in reducing fever, stabilizing lung functions, and reducing the number of days of hospitalization.

RespireAid (NRICM101)
RespireAid (NRICM101)
RespireAid (NRICM101)
RespireAid (NRICM101)

“Medtecs is committed to combating the COVID-19 pandemic at home and abroad. With RespireAid (NRICM101), we hope to safeguard the health of the people in the Philippines and Cambodia and to share this wonderful Taiwan-developed remedy with the world,” remarked Mr William Yang, Medtecs Group CEO.

Medtecs has long established a strong presence in the Philippines and Cambodia and is currently the biggest non-China-based personal protective equipment (PPE) provider in the Asia Pacific region. Medtecs believes the distribution of RespireAid (NRICM101) will further enhance the company’s position as a total solution provider for everyone’s infection prevention and health needs.

Latest Articles

Related Articles

Indexn Medtecs

Medtecs participates for the first time in world’s leading nonwovens exhibition – INDEX™20 in Europe Showcasing Taiwan’s medical equipment technology in preventing HAIs during and post-pandemic

Renowned as one of the world’s three largest nonwovens exhibitions together with the IDEA in USA and ANEX in Asia, INDEX is held once every three years and comprises a total of six categories including: Filtration, Geotextiles & Civil Engineering, Hygiene & Cleaning, Medical: Infection Prevention, Transportation, and Packaging – attracting prominent exhibitors of the nonwovens industry from around the world. More than 730 nonwovens exhibitors from over 43 countries have registered to date and it is expected that the exhibition will attract 12,700 visitors from more than 100 countries. A virtual exhibition will also be made available online for the first time in history to accommodate the pandemic and to engage people who are unable to physically attend.

Read More »

Medtecs Safeguards the Health and Safety of School Children this Fall with Launch of 6 Colorful Face Masks on Amazon

According to medical experts, children under the age of 12 who are not yet eligible for vaccination are at high risk for infection by the Delta variant. In response, the U.S. Center for Disease Control and Prevention issued an advisory on August 5, 2021, recommending universal masking for children, educators, and visitors to k-12 schools, regardless of vaccination status, as part of the prevention strategy.

Read More »
Medtecs CEO

Medtecs Builds Resilience for Sustainable Growth

Apart from offline channels like convenience shops and department stores, the Group also leverages major e-commerce sites such as Alibaba and Amazon to sell its PPE range. “We’re also looking to set up distribution channels across North America, Japan and Europe to extend the reach of our products.”

Read More »
Scroll to Top